Psychological DistressSTREAMNCT02289014
Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1)
A study testing online stress Management program in people with Psychological Distress and Cancer, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
Many cancer patients experience their illness as substantial psychological burden. About half of the cancer patients suffer from severe stress symptoms and around one third of the patients fulfill the criteria for a clinically relevant psychological disorder (mainly anxiety disorder and/or major depression). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Psychological Distress, Cancer
- What is being tested?
- online stress Management program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 129 participants
- Where
- 1 siteSwitzerland
- Study dates
- Jan 2014to Mar 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients with any kind of newly diagnosed cancer undergoing first treatment (including radiotherapy, hormonal treatment, targeted therapies, chemotherapy or combined-modality treatment) regardless of the setting (adjuvant treatment, curative treatment, palliative first-line treatment)
- Patients with newly diagnosed relapse of cancer, who had received prior curatively-intended treatment
- Inclusion is allowed immediately prior to or within 12 weeks of the start of treatment
- Patients must have cytologically or histologically proven diagnosis of malignant disease (either at diagnosis or at relapse)
- Prior treatment -including chemotherapy- for a different, prior malignant tumor is allowed
- Concomitant participation in an experimental therapeutic drug trial is allowed
Show all 10Show fewer
- Age >18 years
- Command of the German language
- Internet access and basic computer skills
- Life expectancy of >6 months
Who cannot join
- Patients undergoing palliative second- or further line chemotherapy treatment
- Patients treated with surgery only
- Patients participating in a concomitant psychological intervention trial
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1): A Randomized, Wait-list Controlled Intervention Study
Many cancer patients experience their illness as substantial psychological burden. About half of the cancer patients suffer from severe stress symptoms and around one third of the patients fulfill the criteria for a clinically relevant psychological disorder (mainly anxiety disorder and/or major depression). Studies show, that a high level of distress in cancer patients is associated with more side effects of and a reduced compliance for oncological treatment.
Today, the efficacy of psycho-oncological interventions is well studied and proven. Besides the reduction of levels of anxiety, distress and depression, psycho-oncological support facilitates dealing with physical complaints and increases quality of life. Yet, psycho-oncological support is rarely utilized by male patients and insufficiently accessible for many patients (i.a. lack of supply in the respective area, cost issues).
The internet overcomes some of these barriers, as it can be used independently of time and location. Internet-based therapies are therefore a growing field of interest in research and there is evidence for treatment efficacy for several psychological disorders. Moreover effect sizes of traditional face-to-face and interactive web-based interventions are comparable. However, web-based interventions for cancer patients are still scarce. The present research project therefore develops a comprehensive stress management program accessible for a vast number of cancer patients. The study targets primarily to evaluate the feasibility of the program (technical, organizational feasibility, accessibility). In addition, the preliminary efficacy of the program will be analyzed in order to adapt future programs for specific patient groups.
Read the detailed description
The present study is designed as a randomized controlled wait-list intervention study. Within 12 weeks of the start of anti-cancer treatment, patients will be randomly assigned to the web-based stress management intervention or a wait-list control condition.
Inclusion criteria:
Patients with any kind of newly diagnosed cancer undergoing first Treatment regardless of the Setting. Patients undergoing first treatment for newly diagnosed relapse of cancer, who have received prior curatively-intended Treatment.
Inclusion is allowed immediately prior to or within 12 weeks of the start of treatment. If surgery was performed initially and is followed by systemic treatment or radiotherapy, start of systemic treatment or radiotherapy is counted as first treatment. Prior treatment -including chemotherapy- for a different, prior malignant tumor is allowed. Concomitant participation in an experimental therapeutic drug trial is allowed. Age >18 years. Command of the German language. Internet access and basic computer skills. Life expectancy of >6 months.
Exclusion criteria:
Patients undergoing second- or further line treatment. Patients treated with surgery only. Patients participating in a concomitant psychological intervention trial
- Conditions
- Psychological Distress, Cancer
- Being tested
- online stress Management program
- Keywords
- online intervention, stress management, cognitive behavioral therapy, acceptance and mindfulness based intervention
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
online stress Management programOther
Active treatment group
| Study group | Role | What they receive |
|---|---|---|
| Wait-list control group | No intervention | Wait-list control group |
| Active treatment group | Experimental | online stress Management program Receives: Other: online stress Management program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dropout rate during the internet-based recruitment procedure
Measured: Measures assessed at time point of recruitment
Characteristics (Sociodemographic and medical history; i.e. age, gender, education, cancer diagnosis and cancer treatment) of the population willing to participate in an online stress management program shortly after diagnosis of cancer
Measured: Measures assessed at time point of recruitment
Number of participants who completed at least 6 out of 8 modules, i.e. 75 % of each module
Measured: participants will be followed for the duration of the intervention, an expected average of 8 weeks
Working Alliance scores on the Working Alliance (WAI) Questionnaire
Measured: participants will be followed for the duration of the intervention, an expected average of 8 weeks
Usability scores on the System Usability Scale (SUS)
Measured: participants will be followed for the duration of the intervention, an expected average of 8 weeks
Client satisfaction on the Client Satisfaction Questionnaire-8 (CSQ-8)
German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used
Measured: Measures assessed after 8 weeks
Secondary outcomes (4)
Psychological distress on the Distress Thermometer (visual analogue scale)
Measured: Change measures (e.g., "baseline, 8 weeks")
Anxiety and Depression scores on the Hospital Anxiety and Depression Scale (HADS)
Measured: Change measures (e.g., "baseline, 8 weeks")
Quality of life and fatigue scores on the Functional Assessment in Cancer Therapy-Fatigue (FACT-F)
Measured: hange measures (e.g., "baseline, 8 weeks")
Avoidance and psychological inflexibility scores on the Acceptance and Action questionnaire (AAQ)
German Version of the Acceptance and Action questionnaire: Fragebogen zur Akzeptanz und Handeln (FAH II) will be used
Measured: ange measures (e.g., "baseline, 8 weeks")
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2014 (estimated)
- Study startJan 2014
- Primary completionMar 2017
- Study completionMar 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Psychological DistressStudies of the same condition, open and under way.
- More trials run by University Hospital, Basel, SwitzerlandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 129 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Collaborators
- Krebsforschung Schweiz, Bern, Switzerland, Swiss National Science Foundation
- Responsible party
- Sponsor
- Investigators
- Corinne Urech, Dr. phil., Principal investigator, University Hospital, Basel, Switzerland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02289014
- Sponsor's protocol ID
- KFS-3260-08-2013
- Acronym
- STREAM
- Status last verified
- May 2017
- First submitted
- 9 Oct 2014
- Last updated
- 8 May 2017
- Results posted
- No
- Data monitoring committee
- No
Publications
Urech C, Grossert A, Alder J, Scherer S, Handschin B, Kasenda B, Borislavova B, Degen S, Erb J, Faessler A, Gattlen L, Schibli S, Werndli C, Gaab J, Berger T, Zumbrunn T, Hess V. Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study. J Clin Oncol. 2018 Mar 10;36(8):780-788. doi: 10.1200/JCO.2017.74.8491. Epub 2018 Jan 25.
PubMed 29369731Grossert A, Urech C, Alder J, Gaab J, Berger T, Hess V. Web-based stress management for newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention study. BMC Cancer. 2016 Nov 3;16(1):838. doi: 10.1186/s12885-016-2866-0.
PubMed 27809796
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1): A Randomized, Wait-list Controlled Intervention Study
- ClinicalTrials.gov ID
- NCT02289014
- Acronym / sponsor ID
- STREAM / KFS-3260-08-2013
- Conditions
- Psychological Distress, Cancer
- Keywords
- online intervention, stress management, cognitive behavioral therapy, acceptance and mindfulness based intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 129 participants (actual)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Collaborators
- Krebsforschung Schweiz, Bern, Switzerland, Swiss National Science Foundation
- Study start
- Jan 2014
- Primary completion
- Mar 2017 (actual)
- Study completion
- Mar 2017 (actual)
- First posted
- 13 Nov 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many cancer patients experience their illness as substantial psychological burden. About half of the cancer patients suffer from severe stress symptoms and around one third of the patients fulfill the criteria for a clinically relevant psychological disorder (mainly anxiety disorder and/or major depression). Studies show, that a high level of distress in cancer patients is associated with more side effects of and a reduced compliance for oncological treatment.
Today, the efficacy of psycho-oncological interventions is well studied and proven. Besides the reduction of levels of anxiety, distress and depression, psycho-oncological support facilitates dealing with physical complaints and increases quality of life. Yet, psycho-oncological support is rarely utilized by male patients and insufficiently accessible for many patients (i.a. lack of supply in the respective area, cost issues).
The internet overcomes some of these barriers, as it can be used independently of time and location. Internet-based therapies are therefore a growing field of interest in research and there is evidence for treatment efficacy for several psychological disorders. Moreover effect sizes of traditional face-to-face and interactive web-based interventions are comparable. However, web-based interventions for cancer patients are still scarce. The present research project therefore develops a comprehensive stress management program accessible for a vast number of cancer patients. The study targets primarily to evaluate the feasibility of the program (technical, organizational feasibility, accessibility). In addition, the preliminary efficacy of the program will be analyzed in order to adapt future programs for specific patient groups.
Detailed description
The present study is designed as a randomized controlled wait-list intervention study. Within 12 weeks of the start of anti-cancer treatment, patients will be randomly assigned to the web-based stress management intervention or a wait-list control condition.
Inclusion criteria:
Patients with any kind of newly diagnosed cancer undergoing first Treatment regardless of the Setting. Patients undergoing first treatment for newly diagnosed relapse of cancer, who have received prior curatively-intended Treatment.
Inclusion is allowed immediately prior to or within 12 weeks of the start of treatment. If surgery was performed initially and is followed by systemic treatment or radiotherapy, start of systemic treatment or radiotherapy is counted as first treatment. Prior treatment -including chemotherapy- for a different, prior malignant tumor is allowed. Concomitant participation in an experimental therapeutic drug trial is allowed. Age >18 years. Command of the German language. Internet access and basic computer skills. Life expectancy of >6 months.
Exclusion criteria:
Patients undergoing second- or further line treatment. Patients treated with surgery only. Patients participating in a concomitant psychological intervention trial
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Wait-list control group | No intervention | –Wait-list control group |
| Active treatment group | Experimental | Other: online stress Management programonline stress Management program |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- Patients with any kind of newly diagnosed cancer undergoing first treatment (including radiotherapy, hormonal treatment, targeted therapies, chemotherapy or combined-modality treatment) regardless of the setting (adjuvant treatment, curative treatment, palliative first-line treatment)
- Patients with newly diagnosed relapse of cancer, who had received prior curatively-intended treatment
- Inclusion is allowed immediately prior to or within 12 weeks of the start of treatment
- Patients must have cytologically or histologically proven diagnosis of malignant disease (either at diagnosis or at relapse)
- Prior treatment -including chemotherapy- for a different, prior malignant tumor is allowed
Key exclusion criteria (3 listed)
- Patients undergoing palliative second- or further line chemotherapy treatment
- Patients treated with surgery only
- Patients participating in a concomitant psychological intervention trial
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| online stress Management programActive treatment group | Other | Active treatment group |
Primary outcome
Dropout rate during the internet-based recruitment procedure
Time frame: Measures assessed at time point of recruitment
Characteristics (Sociodemographic and medical history; i.e. age, gender, education, cancer diagnosis and cancer treatment) of the population willing to participate in an online stress management program shortly after diagnosis of cancer
Time frame: Measures assessed at time point of recruitment
Number of participants who completed at least 6 out of 8 modules, i.e. 75 % of each module
Time frame: participants will be followed for the duration of the intervention, an expected average of 8 weeks
Working Alliance scores on the Working Alliance (WAI) Questionnaire
Time frame: participants will be followed for the duration of the intervention, an expected average of 8 weeks
Usability scores on the System Usability Scale (SUS)
Time frame: participants will be followed for the duration of the intervention, an expected average of 8 weeks
Client satisfaction on the Client Satisfaction Questionnaire-8 (CSQ-8)
Time frame: Measures assessed after 8 weeks
German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used
4 secondary outcomes
Psychological distress on the Distress Thermometer (visual analogue scale)
Time frame: Change measures (e.g., "baseline, 8 weeks")
Anxiety and Depression scores on the Hospital Anxiety and Depression Scale (HADS)
Time frame: Change measures (e.g., "baseline, 8 weeks")
Quality of life and fatigue scores on the Functional Assessment in Cancer Therapy-Fatigue (FACT-F)
Time frame: hange measures (e.g., "baseline, 8 weeks")
Avoidance and psychological inflexibility scores on the Acceptance and Action questionnaire (AAQ)
Time frame: ange measures (e.g., "baseline, 8 weeks")
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2017.
- Derived from this study: PubMed 29369731Urech C, Grossert A, Alder J, Scherer S, Handschin B, Kasenda B, Borislavova B, Degen S, Erb J, Faessler A, Gattlen L, Schibli S, Werndli C, Gaab J, Berger T, Zumbrunn T, Hess V. Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study. J Clin Oncol. 2018 Mar 10;36(8):780-788. doi: 10.1200/JCO.2017.74.8491. Epub 2018 Jan 25.
- Derived from this study: PubMed 27809796Grossert A, Urech C, Alder J, Gaab J, Berger T, Hess V. Web-based stress management for newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention study. BMC Cancer. 2016 Nov 3;16(1):838. doi: 10.1186/s12885-016-2866-0.
Related trials for Psychological Distress
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Not yet recruiting
Hand in Hand: Feasibility of a Compassion-Focused App to Support Parents of Children With Mental Health Problems
Physiological Conditions, Distress, Emotional
Active, not recruiting
HRVB for Stress and Anxiety During Dentistry Students' Clinical Transition
Stress (Psychology), Anxiety
Recruiting
Effects of a Mindful Self-Compassion Intervention on Psychological Adjustment in Breast Cancer Survivors
Breast Cancer
Not yet recruiting
Group Psychological Intervention to Reduce Distress Among Nursing Undergraduates
Psychological Distress
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Corinne Urech, Dr. phil. principal investigator
University Hospital, Basel, Switzerland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing online stress Management program in people with Psychological Distress and Cancer, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 May 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dropout rate during the internet-based recruitment procedure (time frame: Measures assessed at time point of recruitment). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02289014, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2017.